Read news on ATA-200 gene therapy with our app.
Read more in the app
Atamyo Therapeutics presents promising results in the first patients treated with its ATA-200 gene therapy in the clinical trial targeting LGMD-R5 limb-girdle muscular dystrophy - EurekAlert!
